Scientists Aim to Mutate Avian Flu in Lab to Better Understand its Spread

Diane Barnes, Global Security Newswire
Add to Briefcase
Diane Barnes, Global Security Newswire
Aug. 8, 2013, 12:02 p.m.

WASH­ING­TON — Nearly two dozen vir­o­lo­gists from around the world on Wed­nes­day said they want to modi­fy an emer­ging form of avi­an in­flu­enza in ways that could pro­duce more con­ta­gious, vir­u­lent or drug-res­ist­ant forms of the dis­ease.

The stud­ies would aim to shed light on how the so-called H7N9 vir­us could threaten hu­mans as it mutates in nature, the 22 re­search­ers wrote in a let­ter pub­lished in the journ­als Sci­ence and Nature. Their an­nounce­ment came one day after sci­ent­ists said a Chinese wo­man ap­peared to have caught the vir­us dir­ectly from her fath­er, ul­ti­mately killing both in what might be first case of the germ leap­ing dir­ectly between hu­mans.

The vir­us as of late May had spread to 132 people, 37 of whom had died as a res­ult, ac­cord­ing to the World Health Or­gan­iz­a­tion. China re­por­ted H7N9’s ini­tial jump to a hu­man at the end of March, but that case and those to fol­low ap­peared to be in­stances of trans­mis­sion from in­fec­ted birds.

When dis­eases mutate and take on new cap­ab­il­it­ies — such as the emer­ging trans­mis­sion of avi­an flu from one hu­man to an­oth­er — sci­ent­ists typ­ic­ally seek to study that muta­tion’s “gain of func­tion.” Such ana­lyses aim to de­vel­op a fuller un­der­stand­ing of the muta­tion as a first step to­ward fight­ing it.

“The risk of a pan­dem­ic caused by an avi­an in­flu­enza vir­us ex­ists in nature,” the sci­ent­ists wrote this week. “To an­swer key ques­tions im­port­ant to pub­lic health, re­search that may res­ult in [gain of func­tion] is ne­ces­sary and should be done.”

The pro­pos­al has already pro­voked ques­tions from ex­perts doubt­ful that any sci­entif­ic be­ne­fits from such ex­per­i­ments would out­weigh the risk of a mod­i­fied vir­us es­cap­ing — or be­ing stolen — from a labor­at­ory.

In an in­ter­view with Sci­ence, Prin­ceton Uni­versity mo­lecu­lar bio­lo­gist Ad­el Mah­moud said the pro­pos­al’s sci­entif­ic ra­tionale “is very flimsy, to put it mildly.” He ad­ded: “The claims that it will lead to any­thing use­ful are light­weight.”

In an at­tempt to ad­dress safety and se­cur­ity con­cerns, the let­ter’s au­thors ar­gued that safe­guards and pre­par­a­tion for the new stud­ies have been sig­ni­fic­antly in­formed by earli­er de­bate over gain-of-func­tion stud­ies in­volving an older avi­an flu sub­type, dubbed H5N1. Earli­er this year, flu re­search­ers ended a one-year vol­un­tary morator­i­um on the modi­fic­a­tion of that vir­us, which has been cir­cu­lat­ing among hu­mans since 2003 in a hard-to-catch but highly vir­u­lent form.

“The World Health Or­gan­iz­a­tion is­sued labor­at­ory biosafety guidelines for con­duct­ing re­search on H5N1 trans­mis­sion and, in the United States, ad­di­tion­al over­sight policies and risk-mit­ig­a­tion prac­tices have been put in place or pro­posed,” the Wed­nes­day let­ter states.

Stud­ies should take place un­der strin­gent “Biosafety Level 3 en­hanced” con­di­tions, in­volving safe­guards used in hand­ling po­ten­tially leth­al dis­eases, the re­search­ers said in an ac­com­pa­ny­ing doc­u­ment. Per­son­nel should un­der­go “rel­ev­ant back­ground checks” be­fore be­ing cleared to work with mod­i­fied agent, they said.

Re­search in­sti­tu­tions seek­ing U.S. funds to carry out cer­tain kinds of changes to the vir­us would see their grant re­quests un­der­go spe­cial re­view, Health and Hu­man Ser­vices De­part­ment of­fi­cials said in a state­ment made pub­lic on Wed­nes­day. However, the as­sur­ances of ad­di­tion­al scru­tiny ap­plied solely to pro­posed ex­per­i­ments deemed likely to in­crease the agent’s air­borne trans­miss­ib­il­ity.

A Chinese study has re­vealed an H7N9 vir­us strain already cap­able of passing through the air between fer­rets, a mam­mal of­ten used as a mod­el for hu­man trans­mis­sion.

H7N9 pro­duces its most severe hu­man symp­toms after tak­ing root in the lungs, but vir­us particles can also cause loc­al­ized in­fec­tions on “any mu­cous mem­brane,” in­clud­ing in the mouth, eyes and up­per res­pir­at­ory tract, said Amesh Adalja, a seni­or as­so­ci­ate with the Cen­ter for Health Se­cur­ity at the Uni­versity of Pitt­s­burgh Med­ic­al Cen­ter.

The agent can­not spread ef­fect­ively through the di­gest­ive sys­tem, Adalja ad­ded by tele­phone on Thursday.

The pause in H5N1 re­search took ef­fect after a U.S. bi­o­se­c­ur­ity pan­el aired wor­ries that find­ings from such re­search could po­ten­tially help bad act­ors en­gin­eer an en­hanced vir­us for an act of bi­o­ter­ror­ism.

However, de­bate dur­ing the morator­i­um “fo­cused over­whelm­ingly on the risks of ac­ci­dent­al re­lease of mod­i­fied mi­crobes,” ac­cord­ing to Der­rin Culp, a re­search as­so­ci­ate at Columbia Uni­versity’s Na­tion­al Cen­ter for Dis­aster Pre­pared­ness.

Bi­o­ter­ror­ism came up only “oc­ca­sion­ally” in dis­cus­sions among of­fi­cials and re­search­ers, and at no point was there any high-pro­file look at “the risk of de­lib­er­ate re­lease by an in­sider,” he wrote in April’s edi­tion of the Bul­let­in of the Atom­ic Sci­ent­ists.

Of­fi­cials and in­de­pend­ent ex­perts have gen­er­ally ad­vised giv­ing labor­at­ory man­agers con­sid­er­able free­dom in how they de­cide whom to en­trust with high-risk patho­gens. The ap­proach, he wrote, “would be deemed … naïve and ut­terly in­ad­equate” had more people died as a res­ult of the 2001 an­thrax at­tacks con­tro­ver­sially blamed on a U.S. Army mi­cro­bi­o­lo­gist.

Without ad­dress­ing wheth­er flu-modi­fic­a­tion ex­per­i­ments should be con­tin­ued, Culp said fed­er­al and state le­gis­lat­ors could al­ter pri­vacy stat­utes to “per­mit more in­trus­ive screen­ing and mon­it­or­ing” of in­di­vidu­als who handle dan­ger­ous bio­lo­gic­al agents. Such over­sight might be com­par­able to meas­ures fo­cused on people who work with nuc­le­ar weapons and re­lated ma­ter­i­als, he wrote.

“Mi­cro­bi­o­lo­gists can’t be ex­empt from such scru­tiny,” Culp said. “They lost that priv­ilege when they ac­quired the abil­ity — or merely the po­ten­tial — to gen­er­ate mass cas­u­al­ties.”

What We're Following See More »
Mulvaney: Tax Reform Details Won’t Be Released This Week
5 minutes ago

Despite President Trump's announcement that his tax reform proposal would be released this week, Office of Management and Budget Director Mick Mulvaney now says it will be ready in June. This week's announcement will be limited to "specific governing principles."

Trump To Sign Order Calling For Expanded Drilling
1 hours ago

Donald Trump is expected Monday to sign an executive order which will mark his administration's first action on offshore oil and gas drilling. The order is expected to call for a "review of the locations available for offshore oil and gas exploration and of certain regulations governing offshore oil and gas exploration."

Pence Cuts Asia Trip Short For Big Week
1 hours ago

Vice President Mike Pence has cut his Asia trip short "to race back to Washington, where the Trump administration faces a critical week on tax reform and a funding plan to keep the government running, an aide said on Sunday." Pence will return to Washington on Tuesday morning instead of Wednesday. Trump has a busy week ahead, as he plans to roll out a tax reform on framework, sign a number of executive orders, and works to keep the government open past Friday.

Macron, Le Pen Lead French Elections
3 hours ago

"Centrist Emmanuel Macron and far-right politician Marine Le Pen led the first round of voting in France’s presidential election, according to early projections, as voters redrew the political map, placing the European Union at the center of a new political divide. Projections by the Kantar-Sofres polling firm showed Mr. Macron on track to win the first round with about 24% of the vote, ahead of Ms. Le Pen with nearly 22%." The vote marks the end of the country's dominance by conservative and socialist parties. The top vote-getters head to a runoff on May 7.

Trump to Deliver Keynote for Holocaust Memorial Event
3 hours ago

President Trump will deliver the keynote address for at the National Holocaust Museum's National Day of Remembrance ceremony on Tuesday. He'll speak from the Capitol Rotunda. The move is likely an effort to try to mend fences with Jewish groups. In January, "the White House ignited controversy when it didn't mention Jews or anti-Semitism in a statement on International Holocaust Remembrance Day." And certain members of his inner circle are still suspected of harboring white supremacist or anti-Semitic views."


Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.